May 20 (Reuters) - Pfizer Inc, which has been on a
hot streak with three recent approvals of cancer drugs, stumbled
on Monday, saying it was halting a...
May 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S. companies, including Bank of America and Bl...
Baxter International Inc. (NYSE: BAX) announced today that it will
present at the Deutsche Bank 38th Annual dbAccess Health Care
Conference on Wednesday, May 29, 2013 at 7:00 a.m. (CT).
08:58 AM EDT, 05/20/2013 (MidnightTrader) -- Abbott Laboratories (ABT) has been upgraded at Goldman Sachs to a Buy rating from Neutral. The firm also raised stock's price target to $44 from $38 a share. ABT is up 2% in pre-market action at $37.22...
08:39 AM EDT, 05/20/2013 (MidnightTrader) -- Shares of Baxter International (BAX) are up another 2% today after gaining 2% on Friday after CNBC's Jim Cramer gave his endorsement of a split of the medical products and bioscience divisions to creat...
08:22 AM EDT, 05/20/2013 (MidnightTrader) -- Shares of Abbott Labs (ABT) are up more than 2% in pre-market trading following Goldman's upgrade to Buy from Neutral. The price target was raised to $44.00 from $38.00. ABT last traded at $37.38 with...